메뉴 건너뛰기




Volumn 129, Issue 8, 2014, Pages 907-916

Nonsteroidal anti-inflammatory drugs and the heart

Author keywords

[No Author keywords available]

Indexed keywords

6 METHOXY 2 NAPHTHYLACETIC ACID; ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ETODOLAC; ETORICOXIB; IBUPROFEN; INDOMETACIN; LUMIRACOXIB; MELOXICAM; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PARECOXIB; PIROXICAM; PLACEBO; PROSTAGLANDIN SYNTHASE; ROFECOXIB; THROMBOXANE A2; THROMBOXANE B2; VALDECOXIB;

EID: 84896722503     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.004480     Document Type: Review
Times cited : (96)

References (57)
  • 1
    • 79958243438 scopus 로고    scopus 로고
    • Anti-inflammatory, antipyretic and analgesic agents; Pharmacotherapy of gout
    • Brunton LL, Chabner BA, Knollmann BC, eds. 12th ed. New York: McGraw-Hill
    • Grosser T, Smyth E, FitzGerald GA. Anti-inflammatory, antipyretic and analgesic agents; pharmacotherapy of gout. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 12th ed. New York: McGraw-Hill; 2011:959-1004.
    • (2011) Goodman & Gilman's the Pharmacological Basis of Therapeutics , pp. 959-1004
    • Grosser, T.1    Smyth, E.2    Fitzgerald, G.A.3
  • 2
    • 0035833502 scopus 로고    scopus 로고
    • The coxibs, selective inhibitors of cyclooxygenase- 2
    • FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase- 2. N Engl J Med. 2001;345:433-442.
    • (2001) N Engl J Med , vol.345 , pp. 433-442
    • Fitzgerald, G.A.1    Patrono, C.2
  • 3
    • 0037946702 scopus 로고    scopus 로고
    • Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure
    • García Rodríguez LA, Hernández-Díaz S. Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure. Epidemiology. 2003;14:240-246.
    • (2003) Epidemiology , vol.14 , pp. 240-246
    • García Rodríguez, L.A.1    Hernández-Díaz, S.2
  • 4
    • 31044441042 scopus 로고    scopus 로고
    • Biological basis for the cardiovascular consequences of COX-2 inhibition: Therapeutic challenges and opportunities
    • Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest. 2006;116:4-15.
    • (2006) J Clin Invest , vol.116 , pp. 4-15
    • Grosser, T.1    Fries, S.2    Fitzgerald, G.A.3
  • 5
    • 63649148593 scopus 로고    scopus 로고
    • Nonsteroidal antiinflammatory drugs: Past, present and future
    • Patrono C, Rocca B. Nonsteroidal antiinflammatory drugs: past, present and future. Pharmacol Res. 2009;59:285-289.
    • (2009) Pharmacol Res , vol.59 , pp. 285-289
    • Patrono, C.1    Rocca, B.2
  • 7
    • 84883134602 scopus 로고    scopus 로고
    • Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials
    • Coxib and Traditional NSAID Trialists' (CNT) Collaboration
    • Coxib and Traditional NSAID Trialists' (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382:769-779.
    • (2013) Lancet , vol.382 , pp. 769-779
  • 9
    • 37249068049 scopus 로고    scopus 로고
    • Platelet activation and atherothrombosis
    • Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357:2482-2494.
    • (2007) N Engl J Med , vol.357 , pp. 2482-2494
    • Davì, G.1    Patrono, C.2
  • 11
    • 0023137593 scopus 로고
    • Inhibition of thromboxane formation in vivo and ex vivo: Implications for therapy with platelet inhibitory drugs
    • Reilly IA, FitzGerald GA. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs. Blood. 1987;69:180-186.
    • (1987) Blood , vol.69 , pp. 180-186
    • Reilly, I.A.1    Fitzgerald, G.A.2
  • 13
    • 0019988413 scopus 로고
    • Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects
    • Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest. 1982;69:1366-1372.
    • (1982) J Clin Invest , vol.69 , pp. 1366-1372
    • Patrignani, P.1    Filabozzi, P.2    Patrono, C.3
  • 14
    • 0018741482 scopus 로고
    • Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin
    • Jaffe EA, Weksler BB. Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin. J Clin Invest. 1979;63:532-535.
    • (1979) J Clin Invest , vol.63 , pp. 532-535
    • Jaffe, E.A.1    Weksler, B.B.2
  • 15
    • 0018398906 scopus 로고
    • Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls
    • Moncada S, Vane JR. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med. 1979;300:1142-1147.
    • (1979) N Engl J Med , vol.300 , pp. 1142-1147
    • Moncada, S.1    Vane, J.R.2
  • 16
    • 0019866090 scopus 로고
    • Estimated rate of prostacyclin secretion into the circulation of normal man
    • FitzGerald GA, Brash AR, Falardeau P, Oates JA. Estimated rate of prostacyclin secretion into the circulation of normal man. J Clin Invest. 1981;68:1272-1276.
    • (1981) J Clin Invest , vol.68 , pp. 1272-1276
    • Fitzgerald, G.A.1    Brash, A.R.2    Falardeau, P.3    Oates, J.A.4
  • 17
    • 0021269059 scopus 로고
    • Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation
    • FitzGerald GA, Smith B, Pedersen AK, Brash AR. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N Engl J Med. 1984;310:1065-1068.
    • (1984) N Engl J Med , vol.310 , pp. 1065-1068
    • Fitzgerald, G.A.1    Smith, B.2    Pedersen, A.K.3    Brash, A.R.4
  • 18
    • 0021022903 scopus 로고
    • Arachidonate metabolism in vascular disorders
    • Majerus PW. Arachidonate metabolism in vascular disorders. J Clin Invest. 1983;72:1521-1525.
    • (1983) J Clin Invest , vol.72 , pp. 1521-1525
    • Majerus, P.W.1
  • 24
    • 0029790770 scopus 로고    scopus 로고
    • Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: Cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress
    • Topper JN, Cai J, Falb D, Gimbrone MA Jr. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A. 1996;93:10417-10422.
    • (1996) Proc Natl Acad Sci U S A , vol.93 , pp. 10417-10422
    • Topper, J.N.1    Cai, J.2    Falb, D.3    Gimbrone Jr., M.A.4
  • 28
    • 55049100980 scopus 로고    scopus 로고
    • Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population
    • García Rodríguez LA, Tacconelli S, Patrignani P. Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population. J Am Coll Cardiol. 2008;52:1628-1636.
    • (2008) J Am Coll Cardiol , vol.52 , pp. 1628-1636
    • García Rodríguez, L.A.1    Tacconelli, S.2    Patrignani, P.3
  • 29
    • 33646415952 scopus 로고    scopus 로고
    • Cyclooxygenases, microsomal prostaglandin e synthase-1, and cardiovascular function
    • Cheng Y, Wang M, Yu Y, Lawson J, Funk CD, FitzGerald GA. Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Invest. 2006;116:1391-1399.
    • (2006) J Clin Invest , vol.116 , pp. 1391-1399
    • Cheng, Y.1    Wang, M.2    Yu, Y.3    Lawson, J.4    Funk, C.D.5    Fitzgerald, G.A.6
  • 30
    • 0034971264 scopus 로고    scopus 로고
    • Why there are two cyclooxygenase isozymes
    • Smith WL, Langenbach R. Why there are two cyclooxygenase isozymes. J Clin Invest. 2001;107:1491-1495.
    • (2001) J Clin Invest , vol.107 , pp. 1491-1495
    • Smith, W.L.1    Langenbach, R.2
  • 31
    • 0037076347 scopus 로고    scopus 로고
    • Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases
    • Boutaud O, Aronoff DM, Richardson JH, Marnett LJ, Oates JA. Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases. Proc Natl Acad Sci U S A. 2002;99:7130-7135.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 7130-7135
    • Boutaud, O.1    Aronoff, D.M.2    Richardson, J.H.3    Marnett, L.J.4    Oates, J.A.5
  • 32
    • 38949136999 scopus 로고    scopus 로고
    • Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man
    • Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J. 2008;22:383-390.
    • (2008) FASEB J , vol.22 , pp. 383-390
    • Hinz, B.1    Cheremina, O.2    Brune, K.3
  • 33
    • 0034946873 scopus 로고    scopus 로고
    • Cyclooxygenase-selective inhibition of prostanoid formation: Transducing biochemical selectivity into clinical read-outs
    • Patrono C, Patrignani P, García Rodríguez LA. Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J Clin Invest. 2001;108:7-13.
    • (2001) J Clin Invest , vol.108 , pp. 7-13
    • Patrono, C.1    Patrignani, P.2    García Rodríguez, L.A.3
  • 34
    • 46049108934 scopus 로고    scopus 로고
    • Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    • Patrono C, Baigent C, Hirsh J, Roth G; American College of Chest Physicians. Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(suppl):199S-233S.
    • (2008) Chest , vol.133 , Issue.SUPPL.
    • Patrono, C.1    Baigent, C.2    Hirsh, J.3    Roth, G.4
  • 35
    • 0021163545 scopus 로고
    • Dose-related kinetics of aspirin: Presystemic acetylation of platelet cyclooxygenase
    • Pedersen AK, FitzGerald GA. Dose-related kinetics of aspirin: presystemic acetylation of platelet cyclooxygenase. N Engl J Med. 1984;311:1206-1211.
    • (1984) N Engl J Med , vol.311 , pp. 1206-1211
    • Pedersen, A.K.1    Fitzgerald, G.A.2
  • 41
    • 33744976771 scopus 로고    scopus 로고
    • Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal antiinflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
    • Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal antiinflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006;332:1302-1308.
    • (2006) BMJ , vol.332 , pp. 1302-1308
    • Kearney, P.M.1    Baigent, C.2    Godwin, J.3    Halls, H.4    Emberson, J.R.5    Patrono, C.6
  • 42
    • 80053307147 scopus 로고    scopus 로고
    • Cardiovascular risk with non-steroidal antiinflammatory drugs: Systematic review of population-based controlled observational studies
    • McGettigan P, Henry D. Cardiovascular risk with non-steroidal antiinflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 2011;8:e1001098.
    • (2011) PLoS Med , vol.8
    • McGettigan, P.1    Henry, D.2
  • 44
    • 0037374008 scopus 로고    scopus 로고
    • Validity of indirect comparison for estimating efficacy of competing interventions: Empirical evidence from published meta-analyses
    • Song F, Altman DG, Glenny AM, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003;326:472.
    • (2003) BMJ , vol.326 , pp. 472
    • Song, F.1    Altman, D.G.2    Glenny, A.M.3    Deeks, J.J.4
  • 45
    • 65849268320 scopus 로고    scopus 로고
    • Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials
    • ATT Collaboration
    • ATT Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849-1860.
    • (2009) Lancet , vol.373 , pp. 1849-1860
  • 46
    • 0037635061 scopus 로고    scopus 로고
    • Multicenter Study of Perioperative Ischemia (McSPI) Research Group; Ischemia Research and Education Foundation (IREF) Investigators. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery
    • Ott E, Nussmeier NA, Duke PC, Feneck RO, Alston RP, Snabes MC, Hubbard RC, Hsu PH, Saidman LJ, Mangano DT; Multicenter Study of Perioperative Ischemia (McSPI) Research Group; Ischemia Research and Education Foundation (IREF) Investigators. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2003;125:1481-1492.
    • (2003) J Thorac Cardiovasc Surg , vol.125 , pp. 1481-1492
    • Ott, E.1    Nussmeier, N.A.2    Duke, P.C.3    Feneck, R.O.4    Alston, R.P.5    Snabes, M.C.6    Hubbard, R.C.7    Hsu, P.H.8    Saidman, L.J.9    Mangano, D.T.10
  • 50
    • 76349108251 scopus 로고    scopus 로고
    • Cyclooxygenase-2-dependent prostacyclin formation and blood pressure homeostasis: Targeted exchange of cyclooxygenase isoforms in mice
    • Yu Y, Stubbe J, Ibrahim S, Song WL, Smyth EM, Funk CD, FitzGerald GA. Cyclooxygenase-2-dependent prostacyclin formation and blood pressure homeostasis: targeted exchange of cyclooxygenase isoforms in mice. Circ Res. 2010;106:337-345.
    • (2010) Circ Res , vol.106 , pp. 337-345
    • Yu, Y.1    Stubbe, J.2    Ibrahim, S.3    Song, W.L.4    Smyth, E.M.5    Funk, C.D.6    Fitzgerald, G.A.7
  • 53
    • 4344661128 scopus 로고    scopus 로고
    • Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: Randomised controlled trial
    • Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, Gitton X, Krammer G, Mellein B, Matchaba P, Gimona A, Hawkey CJ; TARGET Study Group. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet. 2004;364:665-674.
    • (2004) Lancet , vol.364 , pp. 665-674
    • Schnitzer, T.J.1    Burmester, G.R.2    Mysler, E.3    Hochberg, M.C.4    Doherty, M.5    Ehrsam, E.6    Gitton, X.7    Krammer, G.8    Mellein, B.9    Matchaba, P.10    Gimona, A.11    Hawkey, C.J.12
  • 54
    • 84859773681 scopus 로고    scopus 로고
    • American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
    • Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P; American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64:465-474.
    • (2012) Arthritis Care Res (Hoboken) , vol.64 , pp. 465-474
    • Hochberg, M.C.1    Altman, R.D.2    April, K.T.3    Benkhalti, M.4    Guyatt, G.5    McGowan, J.6    Towheed, T.7    Welch, V.8    Wells, G.9    Tugwell, P.10
  • 55
    • 34247464709 scopus 로고    scopus 로고
    • Use of nonsteroidal antiinflammatory drugs: An update for clinicians: A scientific statement from the American Heart Association
    • Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA; American Heart Association. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007;115:1634-1642.
    • (2007) Circulation , vol.115 , pp. 1634-1642
    • Antman, E.M.1    Bennett, J.S.2    Daugherty, A.3    Furberg, C.4    Roberts, H.5    Taubert, K.A.6
  • 57
    • 84874489375 scopus 로고    scopus 로고
    • Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: An examination of sales and essential medicines lists in low-, middle-, and high-income countries
    • McGettigan P, Henry D. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med. 2013;10:e1001388.
    • (2013) PLoS Med , vol.10
    • McGettigan, P.1    Henry, D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.